Preclinical Efficacy of Tasquinimod in Myelodysplastic Neoplasms: Restoring Erythropoiesis and Mitigating Bone Loss
Manja Wobus, Heike Weidner, Rebekka Wehner…·Katja Sockel
This study evaluates tasquinimod's efficacy in MDS by showing it reduces inflammation, improves erythropoiesis, and enhances bone health in a mouse model.